Your browser doesn't support javascript.
loading
Cytokeratin 20 [CK-20] a prognostic marker in TCC of the bladder
Benha Medical Journal. 1995; 12 (2): 165-175
in English | IMEMR | ID: emr-36554
ABSTRACT
This immunohistochemical study has examined the degree and pattern of expression of a recently identified cytokeratin [CK-20] in 10 cases of normal bladder urothelium and 15 cases of TCC with well documented clinical course, using immunoperoxidase technique. In normal urothelium the expression of CK-20 was found to be differentiation related and confined to the superficial highly differentiated "umbrella" cells. Correlation of the expression of CK-20 with the clinical course in TCC of the bladder revealed that 85.71 of superficial bladder tumour with good outcome had retained a high degree of expression of CK-20 in the surface cell layer, whereas 80% of muscle invasive tumours, with aggressive clinical course, showed negative expression of the antigen. These observations suggest that the degree and pattern of expression of CK-20 is parallel to the outcome of the tunour. which may make CK-20 a useful prognositc marker in TCC of the bladder. There was another group which showed heterogenous pattern of expression of CK-20. This group was represented mainly by 3 cases of T1 tunours and who had one or more recurrences during the period of follow-up
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Prognosis / Immunohistochemistry / Carcinoma, Transitional Cell / Biomarkers, Tumor / Urothelium / Keratins Limits: Female / Humans / Male Language: English Journal: Benha Med. J. Year: 1995

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Prognosis / Immunohistochemistry / Carcinoma, Transitional Cell / Biomarkers, Tumor / Urothelium / Keratins Limits: Female / Humans / Male Language: English Journal: Benha Med. J. Year: 1995